相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Clinical and economic impact of urinary tract infections caused by ESBL-producing Escherichia coli requiring hospitalization: A matched cohort study
E. Esteve-Palau et al.
JOURNAL OF INFECTION (2015)
Impact of extended-spectrum β-lactamase-producing organisms on clinical and economic outcomes in patients with urinary tract infection
Shawn H. MacVane et al.
JOURNAL OF HOSPITAL MEDICINE (2014)
Costs of Bloodstream Infections Caused by Escherichia coli and Influence of Extended-Spectrum-β-Lactamase Production and Inadequate Initial Antibiotic Therapy
Mario Tumbarello et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Risk factors and treatment outcomes of community-onset bacteraemia caused by extended-spectrum β-lactamase-producing Escherichia coli
Cheol-In Kang et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Impact of Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae on the Outcome of Community-onset Bacteremic Urinary Tract Infections
Ya-Sung Yang et al.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2010)
Bloodstream infections caused by extended-spectrum-beta-lactamase-producing Escherichia coli: Risk factors for inadequate initial antimicrobial therapy
Mario Tumbarello et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Prevalence and risk factor analysis of trimethoprim-sulfamethoxazole- and fluoroquinolone-resistant Escherichia coli infection among emergency department patients with pyelonephritis
David A. Talan et al.
CLINICAL INFECTIOUS DISEASES (2008)
Prevalence and spread of extended-spectrum beta-lactamase-producing Enterobacteriaceae in Europe
R. Canton et al.
CLINICAL MICROBIOLOGY AND INFECTION (2008)
Predictors of mortality from community-onset bloodstream infections due to extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae
Anucha Apisarnthanarak et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2008)
Clinical and molecular epidemiology of community-onset, extendedspectrum β-lactamase-producing Escherichia coli infections in Thailand:: A case-case-control study
Anucha Apisarnthanarak et al.
AMERICAN JOURNAL OF INFECTION CONTROL (2007)
Mortality following bacteraemic infection caused by extended spectrum beta-lactamase (ESBL) producing E-coli compared to non-ESBL producing E-coli
Mark Melzer et al.
JOURNAL OF INFECTION (2007)
Bacteremia due to extended-spectrum β-lactamase producing Escherichia coli in the CTX-M era:: A new clinical challenge
Jesus Rodriguez-Bano et al.
CLINICAL INFECTIOUS DISEASES (2006)
Clinical and economic impact of bacteremia with extended-spectrum-β-lactamase-producing Enterobacteriaceae
MJ Schwaber et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Influx of extended-spectrum β-lactamase producing enterobacteriaceae into the hospital
R Ben-Ami et al.
CLINICAL INFECTIOUS DISEASES (2006)
Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum β-lactamases
E Calbo et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Emergence of Enterobacteriaceae producing extended-spectrum β-lactamases (ESBLs) in the community
JDD Pitout et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Impact of inadequate initial antimicrobial therapy on mortality in infections due to extended-spectrum β-lactamase-producing Enterobacteriaceae -: Variability by site of infection
EP Hyle et al.
ARCHIVES OF INTERNAL MEDICINE (2005)
Risk factors for the development of extended-spectrum beta-lactamase-producing bacteria in nonhospitalized patients
R Colodner et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2004)
Population-based laboratory surveillance for Escherichia coli-producing extended-spectrum β-lactamases:: Importance of community isolates with blaCTX-M genes
JDD Pitout et al.
CLINICAL INFECTIOUS DISEASES (2004)
Infections associated with uremia and dialysis
VR Minnaganti et al.
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2001)
Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae:: Risk factors for infection and impact of resistance on outcomes
E Lautenbach et al.
CLINICAL INFECTIOUS DISEASES (2001)
分享论文
